(Date:8/29/2008)...PRNewswire-FirstCall/ -- Aflac Incorporated,(NYSE:...nalyst meeting that,will be conducted in Tokyo, Ja...ales force will discuss the company,s operations i... 7, 2008, 8:00 p.m. - 2:30 a.m. United States EDT ...ime) Introductions, Kenneth S. Janke Jr. - Senio...
(Date:8/29/2008)...RNewswire/ -- Conseco Insurance Company, a life,an...ailability of its new,indexed universal life insu...ides upside potential with downside protection., ...licy that offers the,opportunity for long-term cas...f 1%. Clients can customize their coverage levels ...
(Date:8/29/2008)...d that Obama failed to address the issue, DENVER,...e Democratic,National Convention Wednesday night, ...orated response to the domestic HIV/AIDS epidemic ...inee Barack Obama, Clinton said,"He will continue...rship in,an area in which I am deeply involved: th...
(Date:8/29/2008)...romosomal change that raises odds for malignancy, ...ay News) -- Some Japanese survivors of the World W... experienced key genetic changes that may have spa...search indicates. , Papillary thyroid cancer (P...tation involving the so-called BRAF gene. But Japa...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Webcast Tokyo Analysts Meeting 2Health News:Aflac Incorporated to Webcast Tokyo Analysts Meeting 3Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 2Health News:Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention 3Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 2Health News:Some Hiroshima Survivors at Thyroid Cancer Risk 3(Date:8/28/2008)...ria, Aug. 28 /- Intercell AG (VSE: IC...Co., Inc. has initiated a Phase II,clinical trial ...tion of,Staphylococcus aureus (S. aureus) infectio...ed study aims to evaluate the safety and immunogen...d-stage kidney disease on,hemodialysis. This trial...
(Date:8/27/2008)...search Team Makes Crucial Breakthrough in Battle t...s Disease, CHICAGO, Aug. 27 /- The B...unced that scientists at The University of Notting... to slow or prevent the onset,of a very common typ...rchers have genetically produced the first ever mo...
(Date:8/26/2008)...to present data from landmark SYNTAX clinical tria...-- Boston Scientific,Corporation (NYSE: BSX ) tod...vents and press announcements at the European Soci...ugust 30 to September 3 in Munich, Germany., The ...YNTAX trial,which compares percutaneous coronary ...
(Date:8/26/2008)...., Aug. 26 /- Cambridge Research &,In... the Maestro(TM) EX In,Vivo Imaging System. The ne...technology and becomes the entry-level instrument ...to: http://www.newscom.com/cgi-bin/prnh/20080826/...ant advancement of CRi,s unique,solid-state tunabl...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4CRi Announces New Maestro(TM) EX In Vivo Imaging System with Improved Performance and an Affordable Price 2Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 1Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 2Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 3Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 4Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 5Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 6Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 7Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 8Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 9Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 10Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 11Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 12Thermo Fisher Scientific Reports Record 2008 First Quarter Revenues and Operating Performance 4831 13ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications 1888 1ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications 1888 2ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications 1888 3Get INSPI 28RED 29 This Mothers Day 17608 1Get INSPI 28RED 29 This Mothers Day 17608 2Get INSPI 28RED 29 This Mothers Day 17608 3Get INSPI 28RED 29 This Mothers Day 17608 4The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week 28April 19 26 29 1885 1The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week 28April 19 26 29 1885 2The COSHAR Foundation Launches National Childhood Immunization Awareness Campaign During National Infant Immunization Week 28April 19 26 29 1885 3...W ORLEANS, March 26, 2007 /PRNewswire/ -- A large ...ER(R) Sirolimus-eluting,Coronary Stent reported fa...ollow-up, according to clinical investigators at t...(ACC.07). , The MATRIX Registry is a prospective, ... of percutaneous coronary intervention (PCI,or bal...
...NEAPOLIS--(BUSINESS WIRE)--Mar 26, 2007 - Two-year...I trial confirm the positive,clinical profile of t...ng to nearly 1,300 the number of Endeavor patients...cantly, among those 1,300,Endeavor patients, there...sis using the independent, pre-specified clinical ...
Other Medicine Technology:Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 2Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 3Two-Year Patient Registry Results Support Safety and Efficacy of,Cypher Sirolimus-Eluting Coronary Stent in 'Real World' Uses 4Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 2Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm,Stent's Positive Clinical Profile 3... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: